Lannett Company
LCI
#10382
Rank
NZ$12.77 M
Marketcap
NZ$1.19
Share price
0.00%
Change (1 day)
-69.39%
Change (1 year)

Lannett Company (LCI) - Cash on Hand

Cash on Hand as of March 2023 : NZ$80.56 Million

According to Lannett Company's latest financial reports the company has NZ$80.56 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Lannett Company - Cash on Hand chart (from 2000 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2022-06-30NZ$0.14 B5.59%
2021-06-30NZ$0.13 B-40.41%
2020-06-30NZ$0.22 B7.25%
2019-06-30NZ$0.20 B43.3%
2018-06-30NZ$0.14 B-26.41%
2017-06-30NZ$0.19 B-40.9%
2016-06-30NZ$0.33 B6.25%
2015-06-30NZ$0.31 B88.71%
2014-06-30NZ$0.16 B152.52%
2013-06-30NZ$66.1 M81.5%
2012-06-30NZ$36.42 M22.35%
2011-06-30NZ$29.76 M-8.49%
2010-06-30NZ$32.52 M-20.34%
2009-06-30NZ$40.83 M396.53%
2008-06-30NZ$8.22 M21.76%
2007-06-30NZ$6.75 M773.42%
2006-06-30NZ$0.77 M-87.3%
2005-06-30NZ$6.09 M-56.56%
2004-06-30NZ$14.01 M131.33%
2003-06-30NZ$6.06 M
1999-06-30NZ$0.18 M488.32%
1998-06-30NZ$0.03 M40.56%
1997-06-30NZ$0.02 M-38.09%
1996-06-30NZ$0.03 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Pfizer
PFE
NZ$25.93 B 32,095.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$32.13 B 39,783.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$13.38 B 16,515.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$16.88 B 20,856.17%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
GlaxoSmithKline
GSK
NZ$7.69 B 9,449.59%๐Ÿ‡ฌ๐Ÿ‡ง UK